A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of infliximab
(Remicade) in patients with Ulcerative Colitis. Infliximab (Remicade) targets specific
proteins in the body's immune system to help control the development of inflammation to help
reduce painful disease.